Fatemeh Talebian

1.9k total citations · 2 hit papers
27 papers, 1.5k citations indexed

About

Fatemeh Talebian is a scholar working on Immunology, Neurology and Genetics. According to data from OpenAlex, Fatemeh Talebian has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Neurology and 8 papers in Genetics. Recurrent topics in Fatemeh Talebian's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Mesenchymal stem cell research (8 papers) and Immune cells in cancer (8 papers). Fatemeh Talebian is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Mesenchymal stem cell research (8 papers) and Immune cells in cancer (8 papers). Fatemeh Talebian collaborates with scholars based in United States, Iran and China. Fatemeh Talebian's co-authors include Mandana Mohyeddin Bonab, Behrouz Nikbin, Ardeshir Ghavamzadeh, Seyed H. Ghaffari, Kamran Alimoghaddam, Xue‐Feng Bai, Jin-Qing Liu, Zhenzhen Liu, Farnaz Hooshmand and Jamshid Lotfi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fatemeh Talebian

27 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aging of mesenchymal stem cell in vitro

2006 685 citations Mandana Mohyeddin Bonab, Kamran Alimoghaddam et al. BMC Cell Biology profile →
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy

2022 178 citations Jin-Qing Liu, Chengxiang Zhang et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fatemeh Talebian United States	14	708	487	435	334	287	27	1.5k
Sadafumi Suzuki Japan	16	799 1.1×	723 1.5×	370 0.9×	394 1.2×	367 1.3×	28	1.9k
César Trigueros Spain	24	647 0.9×	652 1.3×	551 1.3×	340 1.0×	276 1.0×	34	1.8k
Anthony S. Perry United States	10	610 0.9×	621 1.3×	194 0.4×	385 1.2×	223 0.8×	14	1.4k
Aline M. Betancourt United States	14	1.2k 1.6×	532 1.1×	321 0.7×	627 1.9×	328 1.1×	21	1.9k
Robert C.H. Zhao China	18	1.3k 1.9×	608 1.2×	250 0.6×	533 1.6×	264 0.9×	21	1.9k
Marie‐Noëlle Boivin Canada	16	1.1k 1.5×	483 1.0×	566 1.3×	354 1.1×	337 1.2×	24	1.7k
Mo A. Dao United States	19	767 1.1×	734 1.5×	273 0.6×	331 1.0×	350 1.2×	30	1.6k
Moïra François Canada	17	1.5k 2.1×	577 1.2×	425 1.0×	621 1.9×	411 1.4×	24	2.0k
Yuping Han China	10	874 1.2×	552 1.1×	306 0.7×	402 1.2×	336 1.2×	20	1.7k
Gary Brooke Australia	18	1.1k 1.6×	588 1.2×	738 1.7×	768 2.3×	326 1.1×	32	2.5k

Countries citing papers authored by Fatemeh Talebian

Since Specialization

Citations

This map shows the geographic impact of Fatemeh Talebian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Talebian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Talebian more than expected).

Fields of papers citing papers by Fatemeh Talebian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Talebian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Talebian. The network helps show where Fatemeh Talebian may publish in the future.

Co-authorship network of co-authors of Fatemeh Talebian

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Talebian. A scholar is included among the top collaborators of Fatemeh Talebian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Talebian. Fatemeh Talebian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talebian, Fatemeh, Yang Li, Jianmin Zhu, et al.. (2023). CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells. iScience. 26(6). 106904–106904. 5 indexed citations

Hu, Aiyan, Jianmin Zhu, Chunxi Zeng, et al.. (2022). IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. The Journal of Immunology. 208(9). 2239–2245. 10 indexed citations

Liu, Jin-Qing, Chengxiang Zhang, Xinfu Zhang, et al.. (2022). Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. Journal of Controlled Release. 345. 306–313. 178 indexed citations breakdown →

Talebian, Fatemeh, et al.. (2021). CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 9. 739816–739816. 8 indexed citations

Liu, Jin-Qing, Aiyan Hu, Jianmin Zhu, et al.. (2020). CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. Advances in experimental medicine and biology. 1223. 155–165. 47 indexed citations

Fallah, Hamidreza, et al.. (2019). IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder. Metabolic Brain Disease. 35(2). 327–333. 16 indexed citations

Liu, Jin-Qing, Fatemeh Talebian, Lisha Wu, et al.. (2016). A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. The Journal of Immunology. 197(4). 1489–1497. 24 indexed citations

Bai, Xuefeng, Jin-Qing Liu, Fatemeh Talebian, et al.. (2016). A critical role of CD200R signaling in limiting the growth and metastasis of CD200 positive melanoma. The Journal of Immunology. 196(1_Supplement). 72.13–72.13. 1 indexed citations

Wang, Lixin, Jin-Qing Liu, Fatemeh Talebian, et al.. (2015). IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4⁺T cells and promoting CTL persistence in a murine model of plasmacytoma. OncoImmunology. 4(7). e1014232–e1014232. 17 indexed citations

10.

Talebian, Fatemeh. (2012). CD200-CD200R Interaction in Tumor Immunity. OhioLink ETD Center (Ohio Library and Information Network). 2 indexed citations

11.

Talebian, Fatemeh & Xue‐Feng Bai. (2012). The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy. OncoImmunology. 1(6). 971–973. 7 indexed citations

12.

Talebian, Fatemeh, et al.. (2012). Melanoma Cell Expression of CD200 Inhibits Tumor Formation and Lung Metastasis via Inhibition of Myeloid Cell Functions. PLoS ONE. 7(2). e31442–e31442. 39 indexed citations

13.

Liu, Zhenzhen, et al.. (2012). IL‐27 enhances the survival of tumor antigen‐specific CD8⁺ T cells and programs them into IL‐10‐producing, memory precursor‐like effector cells. European Journal of Immunology. 43(2). 468–479. 67 indexed citations

14.

Wang, Lexin, et al.. (2011). IL‐10 Contributes to the Suppressive Function of Tumour‐Associated Myeloid Cells and Enhances Myeloid Cell Accumulation in Tumours. Scandinavian Journal of Immunology. 75(3). 273–281. 14 indexed citations

15.

Wang, Lixin, et al.. (2010). Tumor expression of CD200 inhibits IL‐10 production by tumor‐associated myeloid cells and prevents tumor immune evasion of CTL therapy. European Journal of Immunology. 40(9). 2569–2579. 38 indexed citations

16.

Nikbin, Behrouz, Mandana Mohyeddin Bonab, Farideh Khosravi, & Fatemeh Talebian. (2007). Role of B Cells in Pathogenesis of Multiple Sclerosis. International review of neurobiology. 79. 13–42. 28 indexed citations

17.

Nikbin, Behrouz, Mandana Mohyeddin Bonab, & Fatemeh Talebian. (2007). Microchimerism and Stem Cell Transplantation in Multiple Sclerosis. International review of neurobiology. 79. 173–202. 6 indexed citations

18.

Bonab, Mandana Mohyeddin, Kamran Alimoghaddam, Fatemeh Talebian, et al.. (2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biology. 7(1). 14–14. 685 indexed citations breakdown →

19.

Bonab, Mandana Mohyeddin, et al.. (2005). In Search of Mesenchymal Stem Cells: Bone Marrow, Cord Blood, or Peripheral Blood. SHILAP Revista de lepidopterología. 3 indexed citations

20.

Bonab, Mandana Mohyeddin, et al.. (2005). Assessment of in vitro aging of mesenchymal stem cell. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact